FDA Approved Drugs by Medical Condition

Search by medical condition for drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Select the letter below that corresponds to the first letter of the medical condition you are searching for and all approved drugs classified under that category will be listed below.

Gastric Cancer

Cyramza (ramucirumab) (by Eli Lilly), Approved April 2014
For the treatment of gastric cancer

GastroMARK (by Advanced Magnetics), Approved May 1996
Contrast agent for magnetic resonance imaging of the gastrointestinal tract

Herceptin (trastuzumab) (by Genentech), Approved October 2010
For the treatment of gastric cancer

Stivarga (regorafenib) (by Bayer), Approved February 2013
For the treatment of gastrointestinal stromal tumor

Stivarga (regorafenib) (by Bayer HealthCare Pharmaceuticals), Approved September 2012
For the treatment of previously treated patients with metastatic colorectal cancer

Gastric Ulcers

Cimetadine Hydrochloride Oral Solution 300mg/5ml (by Morton Grove Pharmaceuticals), Approved October 1997
Generic equivalent of Tagamet Oral Solution

Duexis (ibuprofen and famotidine) (by Horizon Pharma), Approved April 2011
For the relief of rheumatoid arthritis and osteoarthritis and prevention of gastric ulcers

Prilosec (omeprazole) (by Astra Merck), Approved March 1996
Treatment for gastric ulcers

Gastroesophageal Reflux Disease (GERD)

Aciphex (rabeprazole sodium) (by Elan Pharmaceuticals), Approved February 2002
For the treatment of symptomatic gastroesophageal reflux disease

Cimetadine Hydrochloride Oral Solution 300mg/5ml (by Morton Grove Pharmaceuticals), Approved October 1997
Generic equivalent of Tagamet Oral Solution

Metozolv ODT (metoclopramide hydrochloride) (by Salix Pharmaceuticals), Approved September of 2009
For the treatment of gastroesophageal reflux and diabetic gastroparesis

Nexium (esomeprazole magnesium) (by AstraZeneca), Approved February 2001
For the eradication of Helicobacter pylori, the healing of erosive esophagitis, and the treatment of symptomatic GERD

Prilosec (omeprazole) (by Astra Merck), Approved December 1996
Treatment for heartburn, gastroesophageal reflux disease (GERD)

Protonix (pantoprazole sodium) Delayed-Release Tablets (by Wyeth), Approved February 2000
For treatment of erosive esophagitis

Protonix (pantoprazole sodium) Intravenous Formulation (by Wyeth), Approved March 2001
For the short-term treatment of gastroesophageal reflux disease

Gastrointestinal Diseases and Disorders

Gattex (teduglutide) (by NPS Pharmaceuticals), Approved December 2012
For the treatment of short bowel syndrome

Protonix (pantoprazole sodium) Delayed Release Tablets (by Wyeth), Approved April 2002
Oral tablets for the treatment of gastroesophageal and pathological hypersecretory conditions

Gaucher Disease

Cerdelga (eliglustat) (by Genzyme), Approved August 2014
For the treatment of certain adult patients with Gaucher disease type 1

Elelyso (taliglucerase alfa) (by Pfizer), Approved May 2012
For the treatment of Gaucher disease

Vpriv (velaglucerase alfa for injection) (by Shire Pharmaceuticals), Approved March 2010
For the treatment of type 1 Gaucher disease

Glaucoma

Zioptan (tafluprost ophthalmic solution) (by Merck), Approved February 2012
For the treatment of elevated intraocular pressure

Gout (Hyperuricemia)

Duzallo (lesinurad and allopurinol) (by Ardea Biosciences), Approved August 2017
For the treatment of hyperuricemia associated with gout

Krystexxa (pegloticase) (by Savient Pharma), Approved September 2010
For the treatment of chronic gout (hyperuricemia)

Zurampic (lesinurad) (by AstraZeneca), Approved December 2015
For the treatment of hyperuricemia associated with gout

Growth Hormone Deficiencies/Abnormalities

Accretropin (somatropin rDNA Original) (by Cangene), Approved January 2008
For the treatment of growth failure in pediatrics

Genotropin (somatropin) injection (by Pharmacia & Upjohn), Approved July 2001
For the treatment of growth failure in children who were born small for gestational age (SGA)

Genotropin (somatropin) lyophilized powder (by Pharmacia & Upjohn), Approved November 1997
Treatment for growth hormone deficiency in adults

Geref (sermorelin acetate for injection) (by Serono Laboratories), Approved October 1997
Treatment for pedicatric growth disorder

Humatrope (somatropin [rDNA origin] for injection) (by Eli Lilly), Approved August 1996
Treatment for Somatropin Deficiency Syndrome

Increlex (mecasermin) (by Tercica), Approved August 2005
For the treatment of growth failure due to Primary IGFD

Norditropin (somatropin (rDNA origin) for injection) (by Novo Nordisk), Approved February 1997
Treatment of children who have growth failure

Nutropin (somatropin-rDNA origin) (by Genentech), Approved December 1997
Treatment for growth hormone deficiency

Nutropin (somatropin-rDNA origin) (by Genentech), Approved January 1996
Treatment that consists of recombinant growth hormone product

Saizen (by Ares-Serono), Approved May 1996
Treatment for growth hormone deficiency and Turner Syndrome